ExodusPoint Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

ExodusPoint Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,443	Closed	-$1.72M	–	2080
2023 Q4	$1.72M	Sell	5,443 -27,868	-84%	-$5.42M	0.01%	627
2023 Q3	$5.63M	Buy	33,311 +10,279	+45%	+$1.93M	0.05%	347
2023 Q2	$4.99M	Buy	+23,032	New	+$4.93M	0.04%	450
2022 Q3	–	Sell	-7,368	Closed	-$932K	–	2410
2022 Q2	$932K	Buy	+7,368	New	+$847K	0.01%	1115

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

ExodusPoint Capital Management's KRTX Position: Q1 2024 in Review

ExodusPoint Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5,443 shares — an estimated $1.72M sold.

ExodusPoint Capital Management first reported a position in KRTX in Q2 2022 and held it in 4 quarters. The position peaked at $5.63M in Q3 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

ExodusPoint Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 5,443 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.72M.
ExodusPoint Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
ExodusPoint Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $5.63M in Q3 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on ExodusPoint Capital Management's 13F filing for Q1 2024, filed 14 May 2024.